This site is intended for healthcare professionals only
LoginRegister
Pfizer growth hormone drug Ngenla gets USFDA okay for pediatric patientsPfizer growth hormone drug Ngenla gets USFDA okay for pediatric patients
Zydus Lifesciences bags USFDA tentative nod for breast cancer drug PalbociclibZydus Lifesciences bags USFDA tentative nod for breast cancer drug Palbociclib
CDSCO Panel Clears MSN Labs Abiraterone Acetate 1000 mg, Mandates Phase IV TrialMSN Lab Gets CDSCO Panel Nod To Manufacture, Market Vigabatrin Powder for Oral Solution
Rick Suarez Named Head of AstraZenecas US Biopharma Business Amid USD 50 Billion Expansion PlanAstraZeneca Xigduo XR approved in China for adults with type 2 diabetes
UP STF Set to Name Pharma Firms in Multi-Crore Codeine Syrup ScamMarion Biotech used toxic industrial grade ingredient in syrup: Sources
DCGI nod to Akums Perampanel Oral Suspension to treat epilepsy seizuresDCGI nod to Akums Perampanel Oral Suspension to treat epilepsy seizures
Dr Prakash A Mody re-appointed as Chairman, MD of Unichem LabsDr Prakash A Mody re-appointed as Chairman, MD of Unichem Labs
Pfizer application for Hemophilia B Gene Therapy Fidanacogene Elaparvovec accepted by USFDAPfizer application for Hemophilia B Gene Therapy Fidanacogene Elaparvovec accepted by USFDA
Gland Pharma reports nearly 50% jump in Q1 profitGland Pharma gets one USFDA observation for Pashamylaram Facility
Sun Pharma, Philogen complete patient enrollment in Phase III trial for Soft Tissue SarcomaSun Pharma Gets CDSCO Panel Nod to Manufacture, Market Gabapentin for neuropathic pain
California man tells jury of getting cancer after using JnJ baby powderCalifornia man tells jury of getting cancer after using JnJ baby powder
Pfizer scraps once-a-day experimental obesity pill over liver safety concernsPfizer scraps once-a-day experimental obesity pill over liver safety concerns
X